Avadel pharmaceuticals appoints kevin springman as vice president of sales

Dublin, feb. 24, 2025 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a biopharmaceutical company focused on transforming medicines to transform lives, announced that kevin springman has joined the company as vice president of sales. mr. springman is an accomplished executive with experience leading sales, market access and commercial teams, and executing rare disease drug launches in competitive markets.
AVDL Ratings Summary
AVDL Quant Ranking